[Diagnosis and therapy of extra-uterine pregnancy].
Gervaise
A
A
hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France.
Fernandez
H
H
D000019:Abortifacient Agents / Q000627:therapeutic use; D000020:Abortifacient Agents, Nonsteroidal / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000465:Algorithms; D003276:Contraceptives, Oral / Q000009:adverse effects; D004359:Drug Therapy, Combination; D004502:Education, Medical, Continuing; D019160:Endosonography / Q000379:methods; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D007434:Intrauterine Devices / Q000009:adverse effects; D010535:Laparoscopy; D008727:Methotrexate / Q000627:therapeutic use; D015735:Mifepristone / Q000627:therapeutic use; D034161:Pelvic Infection / Q000150:complications; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D016896:Treatment Outcome
D000019:Abortifacient Agents; D000020:Abortifacient Agents, Nonsteroidal; D003276:Contraceptives, Oral; D015735:Mifepristone; D008727:Methotrexate